InvestSMART

Respiri Limited (ASX:RSH)

ALERT: Price-sensitive ASX Announcement for RSH
Current share price for RSH : $0.033 -0.015 (-31.25%)+
Announcement
Release
3 Mar 2025 9:43AM
Price at Release
$0.048
Full Release
download
Summary
Respiri Limited has successfully secured approximately A$4 million through a capital raising placement, intended to bolster its growth and execution capabilities in the U.S. healthcare market. The company plans to rebrand as Vitasora Health Limited to reflect its evolution into a comprehensive Care Management Company. The funds will support the scaling of its clinical and sales teams and facilitate investments in technology and marketing, allowing Respiri to enhance patient outcomes and reduce healthcare system costs through innovative remote patient monitoring solutions.
Key Points
  • Respiri receives firm commitments to raise approximately A$4 million via a Placement.
  • Funds raised will support investments in the business to execute on recent and expected customer wins.
  • The proposed name change to Vitasora Health Limited reflects the organisation’s evolution into a full-service Care Management Company.
  • Vitasora represents the Company’s commitment to patient-centric care and enhancing patient outcomes.
  • The Placement will settle in two tranches, with A$2.7 million on about 10 March 2025 and A$1.3 million on about 5 June 2025.
  • The funds raised will enable Respiri to scale its clinical Care Coordinator, sales and account management teams.
  • Respiri plans to make investments in technology, marketing, customer engagement, and general working capital.
  • The company has evolved from a respiratory-focused connected care company to a full-service Care Management leader.
  • Vitasora's bespoke Care Management model integrates remote monitoring, virtual clinical support, and AI-powered decision-making.
  • The name Vitasora reflects a commitment to sustaining patient health and limitless possibilities in transforming healthcare delivery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.